Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 4:35 pm Purchase |
2020-12-31 | 13G | NOVUS THERAPEUTICS INC NVUS |
Woodline Partners LP | 814,756 5.400% |
814,756 (New Position) |
Filing History |
| 2021-02-16 4:17 pm Sale |
2020-12-31 | 13G | NOVUS THERAPEUTICS INC NVUS |
BIOTECHNOLOGY VALUE FUND L P | 1,503,121 9.990% |
-14,918 (-0.98%) |
Filing History |
| 2021-02-16 3:14 pm Purchase |
2020-12-31 | 13G | NOVUS THERAPEUTICS INC NVUS |
683 Capital Management, LLC | 35,900 1.000% |
35,900 (New Position) |
Filing History |
| 2021-02-08 10:29 am Purchase |
2021-02-05 | 13G | NOVUS THERAPEUTICS INC NVUS |
FMR CORP | 1,004,111 6.623% |
1,004,111 (New Position) |
Filing History |
| 2021-01-05 4:38 pm Unchanged |
2020-12-22 | 13D | NOVUS THERAPEUTICS INC NVUS |
OrbiMed Israel BioFund GP Limited Partnership | 73,650 0.500% |
0 (Unchanged) |
Filing History |
| 2021-01-04 4:06 pm Purchase |
2020-12-22 | 13G | NOVUS THERAPEUTICS INC NVUS |
ADAGE CAPITAL PARTNERS GP LLC | 892,555 5.890% |
892,555 (New Position) |
Filing History |
| 2021-01-04 4:01 pm Purchase |
2020-12-22 | 13G | NOVUS THERAPEUTICS INC NVUS |
Cormorant Asset Management LP | 1,415,500 9.890% |
1,415,500 (New Position) |
Filing History |
| 2020-12-30 5:27 pm Purchase |
2020-12-28 | 13G | NOVUS THERAPEUTICS INC NVUS |
BIOTECHNOLOGY VALUE FUND L P | 1,518,039 10.000% |
3,520 (+0.23%) |
Filing History |
| 2020-12-28 5:13 pm Purchase |
2020-12-22 | 13G | NOVUS THERAPEUTICS INC NVUS |
BIOTECHNOLOGY VALUE FUND L P | 1,514,519 9.990% |
1,319,193 (+675.38%) |
Filing History |
| 2020-12-04 5:12 pm Sale |
2020-12-02 | 13D | NOVUS THERAPEUTICS INC NVUS |
OrbiMed Israel BioFund GP Limited Partnership | 73,650 5.100% |
-103,200 (-58.35%) |
Filing History |
| 2020-11-20 4:39 pm Unchanged |
2020-11-16 | 13D | NOVUS THERAPEUTICS INC NVUS |
OrbiMed Israel BioFund GP Limited Partnership | 176,850 12.400% |
0 (Unchanged) |
Filing History |
| 2020-11-09 12:42 pm Purchase |
2020-10-29 | 13G | NOVUS THERAPEUTICS INC NVUS |
Logos Global Management LP | 224,071 15.700% |
224,071 (New Position) |
Filing History |
| 2020-10-13 9:20 pm Purchase |
2020-10-05 | 13D | NOVUS THERAPEUTICS INC NVUS |
OrbiMed Israel BioFund GP Limited Partnership | 176,850 14.100% |
176,850 (New Position) |
Filing History |
| 2020-10-05 5:26 pm Purchase |
2020-10-01 | 13G | NOVUS THERAPEUTICS INC NVUS |
BIOTECHNOLOGY VALUE FUND L P | 195,326 15.600% |
195,326 (New Position) |
Filing History |
| 2020-08-18 4:35 pm Unchanged |
2020-08-14 | 13D | NOVUS THERAPEUTICS INC NVUS |
OrbiMed Israel BioFund GP Limited Partnership | 3,183,314 16.400% |
0 (Unchanged) |
Filing History |